Aggressive prostate myxoid mesenchymal neoplasm with novel CRTC1::NCOA2 fusion

Histopathology. 2024 Apr;84(5):909-912. doi: 10.1111/his.15135. Epub 2024 Jan 3.
No abstract available

Keywords: CRTC1::NCOA2; myxoid mesenchymal neoplasm; novel gene fusion; prostate neoplasm.

Publication types

  • Letter

MeSH terms

  • Biomarkers, Tumor
  • Gene Fusion
  • Humans
  • Male
  • Neoplasms*
  • Nuclear Receptor Coactivator 2 / genetics
  • Oncogene Proteins, Fusion / genetics
  • Prostate* / metabolism
  • Transcription Factors / genetics

Substances

  • Transcription Factors
  • Biomarkers, Tumor
  • Nuclear Receptor Coactivator 2
  • Oncogene Proteins, Fusion
  • NCOA2 protein, human
  • CRTC1 protein, human